• Nenhum resultado encontrado

[PDF] Top 20 Fatigue in a cohort of geriatric patients with and without Parkinson's disease

Has 10000 "Fatigue in a cohort of geriatric patients with and without Parkinson's disease" found on our website. Below are the top 20 most common "Fatigue in a cohort of geriatric patients with and without Parkinson's disease".

Fatigue in a cohort of geriatric patients with and without Parkinson's disease

Fatigue in a cohort of geriatric patients with and without Parkinson's disease

... frequency of fatigue in geriatric patients with and without Parkinson’s disease (PD) and correlated it with depression and excessive ... See full document

5

RET variants and haplotype analysis in a cohort of Czech patients with Hirschsprung disease.

RET variants and haplotype analysis in a cohort of Czech patients with Hirschsprung disease.

... Hirschsprung disease (HSCR) is a congenital developmental malformation characterised by the absence of enteric ganglion cells of myenteric and submucosal plexuses in the ...incidence ... See full document

9

Depression increases in patients with Parkinson?s disease according to the increasing severity of the cognitive impairment

Depression increases in patients with Parkinson?s disease according to the increasing severity of the cognitive impairment

... severity of cognitive impairment modifies the association between depression and Parkinson’s disease ...analysis of 1,451 people aged 65 years and older with cognitive impairment ... See full document

4

Effects of physical activity levels on fatigue perception in patients with Parkinson's disease and neurologically healthy individuals

Effects of physical activity levels on fatigue perception in patients with Parkinson's disease and neurologically healthy individuals

... one of the most common non-motor manifestations in patients with Parkinson’s disease (PD) ...[1]-[4]. Fatigue is multifactorial and has been set as a general sense ... See full document

8

Clinical Characterization of Parkinson s Disease Patients Followed at CHCB Comparison with a control group

Clinical Characterization of Parkinson s Disease Patients Followed at CHCB Comparison with a control group

... cycle of microglia ...levels of cytokines in serum and CSF of PD patients when compared with HC,(9) including pro- inflammatory cytokines, like IL-6 (12, 17), IL-12 (19), ... See full document

70

Juvenile Systemic Lupus Erythematosus in Portugal: clinical and immunological patterns of disease expression in a cohort of 56 patients

Juvenile Systemic Lupus Erythematosus in Portugal: clinical and immunological patterns of disease expression in a cohort of 56 patients

... clinical and laboratory features in our cohort of patients, with and without renal involve- ment, showed that lupus nephritis was notably asso- ciated with ... See full document

12

Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients.

Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients.

... differences in the regulatory approach and labeling of the QT- risks such as recently seen with the very commonly prescribed antidepressant drug citalopram are not ...warning and ... See full document

19

Fluency in Parkinson's disease: disease duration, cognitive status and age

Fluency in Parkinson's disease: disease duration, cognitive status and age

... groups in the present study showed a lower speech rate in the PD than in the ...presence of episodes of accelerated speech rate, character- ized as “speech bursts” in subjects ... See full document

7

Arq. NeuroPsiquiatr.  vol.70 número3

Arq. NeuroPsiquiatr. vol.70 número3

... representative of the routine medical service in geriatric clinics, and it included patients both with and without ...proportion of pa- tients with ... See full document

6

Changes in motor cortex excitability associated with muscle fatigue in patients with Parkinson's disease

Changes in motor cortex excitability associated with muscle fatigue in patients with Parkinson's disease

... affected in fatigue has received the least experimental atten- tion as a possible factor in the development of muscular fa- ...tigue. In fact even though few would argue that the ... See full document

6

Depression in Parkinson's disease: clinical-epidemiological correlates and comparison with a controlled group of non-parkinsonian geriatric patients

Depression in Parkinson's disease: clinical-epidemiological correlates and comparison with a controlled group of non-parkinsonian geriatric patients

... de Parkinson e um grupo sem doença de Parkinson, sem doença neurológica, reumatológica e/ou oncológica acompanhados na Universidade Federal de São ...de Parkinson (grupo Parkinson) e 50 ... See full document

4

Exposure to pesticides and heterozygote genotype of GSTP1-Alw26I are associated to Parkinson's disease

Exposure to pesticides and heterozygote genotype of GSTP1-Alw26I are associated to Parkinson's disease

... ageing and exposure to pesticides, whose ef- fects can be enhanced in combination with I/V genotype of GSTP1-Alw26I, reinforcing the relation between genetic poly- morphisms involved in ... See full document

7

Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.

Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.

... iTUG in patients with Parkinson’s Disease ...range and slope in the accelerometer signal in anterior-posterior direction during the Sit-To-Stand and Stand-To- Sit ... See full document

11

Gene Expression Differences in Peripheral Blood of Parkinson ’s Disease Patients with Distinct Progression Profiles

Gene Expression Differences in Peripheral Blood of Parkinson ’s Disease Patients with Distinct Progression Profiles

... protein, and TCEA1, a transcription elongation factor, are involved in nucleic acid ...Two of the genes identified were also altered in PD patients upon Deep Brain Stimulation (DBS) ... See full document

19

Arq. NeuroPsiquiatr.  vol.75 número4

Arq. NeuroPsiquiatr. vol.75 número4

... symptoms in patients with Parkinson’s disease ...decline in verbal luency performance. We aimed to verify the effects of STN-DBS on the performance of phonemic verbal ... See full document

5

Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort

Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort

... survivors of PTB may number many ...glimpse of the potential magnitude of the importance of TB as a cause of CAL in areas with a high prevalence of TB, and ... See full document

6

Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease

Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease

... impact of combined genetic polymorphisms and environmental factors in neu- rodegenerative ...ducted in various groups of population, in order to charac- terize smaller speciic ... See full document

6

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

... expressions of 10 antibod- ies ...sensitivity and specificity, using a small blood sample. Although the function of a number of antibod- ies is unknown, it has been found that the presence ... See full document

10

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

... associated with the susceptibility, progression or disease protection ...individuals with Ala147/Ala147 (i.e., HABs) have been associated with significantly higher level of low-density ... See full document

10

Unraveling the neuroprotective role of TUDCA in Parkinson´s disease

Unraveling the neuroprotective role of TUDCA in Parkinson´s disease

... son’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s disease was first described in 1817 by James ...loss of dopaminergic neurons of the substantia ... See full document

69

Show all 10000 documents...